Personalizing Oncology Care and the Quest for Companion Diagnostics: A Researcher’s Perspective An Interview with Suso J. Platero, PhD, of Janssen Pharmaceuticals
Today we interview Dr Suso J. Platero, whose research is probing the frontiers of next-generation sequencing, transcriptional profiling, and proteomics in the validation of biomarkers for lung cancers. In his 2009 book, Molecular Pathology in Drug Discovery and Development, Dr Platero makes the case for clinicians and researchers working together [ Read More ]